Dr. Satish Govindaraj, MD

Dr. Govindaraj practices at Head and Neck Surgery Department of Otolaryngology in New York, New York.

Dr. Govindaraj's NPI, 1205871365, was assigned on June 20, 2006. Dr. Govindaraj graduated from Northeast Ohio Medical University in 1999. Dr. Govindaraj's New York license number on file is 226367.

Dr. Govindaraj's primary practice is Head and Neck Surgery Department of Otolaryngology, at 234 E 85th St, New York, NY 10028 in New York County. The practice phone is (212) 241-9410.

Dr. Govindaraj's primary practice is Head and Neck Surgery Department of Otolaryngology in New York, New York. Dr. Govindaraj is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Govindaraj to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Govindaraj practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Govindaraj's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Govindaraj is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Govindaraj's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery and upper respiratory infection (URI) among the conditions Dr. Govindaraj treats.

CMS data shows 1,697 Medicare services from Dr. Govindaraj across 13 procedure codes in 2024, for 448 Medicare patients. Medicare paid $278,629 for them.

CMS counts 448 Medicare patients who saw Dr. Govindaraj in 2024. The largest group is 65 to 74, with 223 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Govindaraj's median patient age at 59, with 45% women.

In 2024, Dr. Govindaraj wrote 1,258 Medicare Part D claims for 345 patients. 98% of them were for generic drugs. CMS names the drug for 1,142 of them, across 19 drugs with 11 or more claims each, at $41,637 in total drug cost. In 2023, CMS named 880 claims across 18 drugs.

Dr. Govindaraj accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 120 papers to Dr. Govindaraj, published from 2009 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Endoscopy, Sinusitis and Postoperative Complications. Dr. Govindaraj has published most often in Int Forum Allergy Rhinol. Dr. Govindaraj's most frequent co-authors are Raj K. Shrivastava, MD, Eric M. Genden, MD and Arjun Parasher, MD.

Dmand AI links Dr. Govindaraj to 3 clinical trials. Conditions studied include Nasal Obstruction, Sinusitis and Airway Obstruction. Icahn School of Medicine at Mount Sinai sponsors the most, 2.

CMS Open Payments shows 343 general payments to Dr. Govindaraj from 24 drug and device companies from 2016 to 2025. Education make up the largest share, 53% of the total. Olympus Corporation of the Americas paid the most, $73,182.

Dmand AI lists 3 awards for Dr. Govindaraj, most recently ACS Fellow in 2013.

Dr. Govindaraj graduated from Northeast Ohio Medical University in 1999. Dr. Govindaraj is a member of NHS and ACS.

Dr. Govindaraj is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.